Consistently, CYH33 time- and dose-dependently suppressed the phosphorylation level of GAB1 at Y659 in sensitive HNSCC cells, whereas it had little effect in resistant cells (Fig. 5B and Fig. S5A, B). This evidence concerns the gene GAB1 and head and neck squamous cell carcinoma.